Induced sputum eosinophilia in ulcerative colitis patients: The lung as a mirror image of intestine?

Respiratory Medicine

Volumn 103, Issue 7, 2009, Pages 1025-1032

  Fireman, Elizabeth ^a,b   Masarwy, Farid ^c,d   Groisman, Gabi ^c,d   Shtark, Moshe ^a,b   Kopelman, Yael ^c,d   Kivity, Shmuel ^a,b   Fireman, Zvi ^c,d  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HILLEL YAFFE MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Eosinophils; Induced sputum; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; MESALAZINE; PREDNISOLONE;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INTESTINE BIOPSY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; ULCERATIVE COLITIS; VITAL CAPACITY;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; EOSINOPHILS; FEMALE; HUMANS; INTESTINES; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; SPUTUM; T-LYMPHOCYTE SUBSETS;

EID: 67349111017     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.01.016     Document Type: Article

References (43)

1. Regueiro M.D. Diagnosis and treatment of ulcerative proctitis. J Clin Gastroenterol 38 (2004) 733-740
2. Danese S., Semeraro S., Papa A., et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11 (2005) 7227-7236
3. Tzanakis N., Bouros D., Samiou M., et al. Lung function in patients with inflammatory bowel disease. Respir Med 92 (1998) 516-522
4. Heatley R.V., Thomas P., Prokipchuk E.J., Gauldie J., Sieniewicz D.J., and Bienenstock J. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med 203 (1982) 241-250
5. Mohamed-Hussein A.A., Mohamed N.A., and Ibrahim M.E. Changes in pulmonary function in patients with ulcerative colitis. Respir Med 101 (2007) 977-982
6. Bonniere P., Wallaert B., Cortot A., et al. Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut 27 (1986) 919-925
7. Karadag F., Ozhan M.H., Akçiçek E., Günel O., Alper H., and Veral A. Is it possible to detect ulcerative colitis-related respiratory syndrome early?. Respirology 6 (2001) 341-346
8. James D., and Rizzato G. Bronchopulmonary lavage (BAL): a window of the lungs. Sarcoidosis 9 (1992) 3-14
9. Fireman E. Induced sputum: opening a new window to the lung. Sarcoidosis Vasc Diffuse Lung Dis 18 (2001) 263-271 [Review]
10. Fireman Z., Osipov A., Kivity S., et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol 95 (2000) 730-734
11. Louis E., Louis R., Shute J., et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 29 (1999) 660-666
12. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel diseases. Nat Rev Immunol 3 (2003) 521-533
13. D'Haens G., Sandborn W.J., Feagan B.G., et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 132 (2007) 763-786
14. Truelove S.C., and Witts L.J. Cortisone in ulcerative colitis: final report on therapeutic trial. Br Med J 2 (1955) 1041-1047
15. Miller M.R., Hankinson J., Brusasco V., et al. ATS/ERS Task Force. ATS/ERS standardization of lung function testing: standardization of spirometry. Eur Respir J 26 (2005) 319-338
16. Pin I., Gibson P.G., Kolendowicz R., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47 (1992) 25-29
17. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., and Hargreave F.E. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy 24 (1994) 778-783
18. Li C.I., Yam L.T., and Crossby W.H. Histochemical characterization of cellular and structural elements of the human spleen. J Histochem Cytochem 20 (1972) 1049-1058
19. Dignass A.U., Baumgart D.C., and Sturm A. The aetiopathogenesis of inflammatory bowel disease - immunology and repair mechanisms. Aliment Pharmacol Ther 209 Suppl. 4 (2004) 9-17
20. Allez M., and Mayer L. Regulatory T cells - peace keepers in the gut. Inflamm Bowel Dis 10 (2004) 666-676
21. Pabst R., and Tschering T. Lymphocyte dynamics: caution in interpreting BAL numbers. Thorax 52 (1997) 1078-1080
22. Carvalho A.T., Elia C.C., De Souza H.S., et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 36 (2003) 120-125
23. Rutgers S.R., Timens W., Kaufmann H.F., van der Mark T.W., Koëter G.H., and Postma D.S. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 15 (2000) 109-115
24. Wallaert B., Desreumaux P., and Copin M. Immunoreactivity of interleukin-3 and -5 and granulocyte/macrophage colony stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 182 (1995) 1898-1904
25. Rothenberg M.E., Mishra A., Brandt E.B., and Hogan S.P. Gastrointestinal eosinophils. Immunol Rev 179 (2001) 139-155
26. Bischoff S.C., Wedemeyer J., Herrmann A., et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28 (1996) 1-13
27. Carlson M., Raab Y., Peterson C., Hällgren R., and Venge P. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol 94 (1999) 1876-1883
28. Peterson C.G., Eklund E., Taha Y., Raab Y., and Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 97 (2002) 1755-1762
29. Bousquet J., Chanez P., and Lacoste J. Eosinophilic inflammation in asthma. N Engl J Med 323 (1990) 1033-1039
30. Hargreave F.E., and Leigh R. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) S53-S57
31. Brightling C.E. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 129 1 Suppl. (2006) 116S-121S
32. Fireman E., Boikaner T., and Priel I.E. Combined CD4/CD8 ratio in induced sputum and pulmonary function testing for non-invasive identification of sarcoidosis. Transl Res 148 (2006) 87-95
33. Rothenberg M.E., and Hogan S.P. The eosinophils. Annu Rev Immunol 24 (2006) 147-174
34. Crystal R.G., Bitterman P.B., Rennard S.I., Hance A.J., and Keogh B.A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310 (1984) 235-244
35. Yaffe B., and Korelitz B. Sulfasalazine pneumonitis. Am J Gastroenterol 78 (1983) 493-494
36. Kelly M.M., Leigh R., Jayaram L., Goldsmith C.H., Parameswaran K., and Hargreave F.E. Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids. Allergy Clin Immunol 117 (2006) 989-994
37. Lampinen M., Backman M., Winqvist O., et al. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis. J Leukoc Biol (2008 Sep 18) [Epub ahead of print]
38. Al-Haddad S., and Riddell R.H. The role of eosinophils in inflammatory bowel disease. Gut 54 (2005) 1674-1675
39. Sarin S.K., Malhotra V., Sen Gupta S., Karol A., Gaur S.K., and Anand B.S. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 32 (1987) 363-367
40. Jeziorska M., Haboubi N., Schofield P., and Woolley D.E. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 194 (2001) 484-492
41. Korelitz B.I., and Sommers S.C. Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and mucosal cell counts. Am J Dig Dis 21 (1976) 441-444
42. Lampinen M., Rönnblom A., Amin K., et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 54 (2005) 1714-1720
43. Phipps S., Ying S., Wangoo A., Ong Y.E., Levi-Schaffer F., and Kay A.B. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 169 (2002) 4604-4612